Intrinsic Value of S&P & Nasdaq Contact Us

Myomo, Inc. MYO AMEX

American Stock Excha • Healthcare • Medical - Devices • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.10
+40.6%

Myomo, Inc. (MYO) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 7 Buy, 1 Hold.

The consensus price target is $1.10, representing an upside of 40.6% from the current price $0.78.

Analysts estimate Earnings Per Share (EPS) of $-0.18 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.16 vs est $-0.18 (beat +11.1%). 2025: actual $-0.37 vs est $-0.34 (missed -7.7%). Analyst accuracy: 90%.

MYO Stock — 12-Month Price Forecast

$1.10
▲ +40.65% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Myomo, Inc., the price target is $1.10.
The average price target represents a +40.65% change from the last price of $0.78.

MYO Analyst Ratings

Buy
8
Ratings
7 Buy
1 Hold
Based on 8 analysts giving stock ratings to Myomo, Inc. in the past 3 months
Rating breakdown
Buy
7 88%
Hold
1 13%
88%
Buy
7 analysts
13%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — MYO

90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.16 vs Est –$0.18 ▲ 12.5% off
2025 Actual –$0.37 vs Est –$0.34 ▼ 7.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — MYO

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.033B vs Est $0.030B ▲ 6.6% off
2025 Actual $0.041B vs Est $0.040B ▲ 2.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message